methotrexate
Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds,        sulfasalazine and methotrexate in the treatment of rheumatoid arthritis: a       clinical trial.
Additive triple DMARD combination therapy of a low dose of sulfhydryl compounds,        sulfasalazine and  @SUBJECT$  in the  @PREDICAT$  of  @OBJECT$ : a       clinical trial.